About Leaphy
A small Belgian team. A pan-European mission.
Leaphy® is a medical-pharmaceutical information and data intelligence company building a clean, modern home for medication leaflets across the EU.
Our story
Bridging approved leaflets with the people who need them.
Leaphy® empowers patients and healthcare providers with structured and user-friendly access to public information leaflets (PILs). Currently in pilot phase, Leaphy® hosts the majority of leaflets for medicines licensed and commercialised in Belgium for human use.
Soon we'll encompass all European leaflets, available in national languages, for widespread use by patients across the continent. Once you download the Leaphy® app, you gain access to a growing set of useful tools for understanding and managing your medication.
We're also a pivotal partner for pharmaceutical companies transforming their leaflets into structured data formats — ensuring optimal usability and helping the industry meet the ePI moment with confidence.
Leaphy strongly recommends consulting your doctor or pharmacist before using any medication.
What we believe
Four values, no committees.
Patient-first
Everything we build starts with the person who'll actually read the leaflet.
Trustworthy by design
Approved sources, audit trails, and standards alignment — never workarounds.
Built for Europe
Belgium today, the entire EU tomorrow — language by language, market by market.
Quietly innovative
We use modern technology to make complex things feel simple, not the other way around.
Where we are
Headquartered in Aalst, Belgium.
20 km from Brussels, in the heart of European healthcare policy. Close enough to walk into the conversation, focused enough to ship the product.
- Founded
- 2019
- VAT
- BE 0711.769.370
- Status
- Pilot · Belgium
Let's build the future of leaflets together.
We work best when we work with you. Drop us a line — patients, clinicians, pharma teams, regulators, all welcome.